A Study of LY3985863 in Healthy Participants

Exclusion Criteria

• •Have known allergies to any components of the LY3985863 formulation
• •Have concomitant disease known to influence skeletal muscle protein
• •Have current or a history of comorbidities capable of significantly altering the absorption, metabolism, or elimination of drugs, of constituting a risk when taking the study medication or completing study procedures, or of interfering with the interpretation of the data
• •Have a 12-lead echocardiogram (ECG) abnormality
• •Have used within 3 months or intend to use medications during the study that promote weight loss